SCHACHLE JOSEPH K 4
4 · Ocuphire Pharma, Inc. · Filed Mar 25, 2024
Insider Transaction Report
Form 4
SCHACHLE JOSEPH K
Chief Operating Officer
Transactions
- Purchase
Common Stock
2024-03-21$2.05/sh+2,000$4,100→ 2,000 total
4 · Ocuphire Pharma, Inc. · Filed Mar 25, 2024
Common Stock